C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) G01N 33/68 (2006.01) C12Q 1/48 (2006.01)
Patent
CA 2680909
A simple two gene expression assay, RASGRPI:APTX, with utility in diagnosing a population of acute myeloid leukemia (AML) patients who are more likely to respond to farbesyltransferase inhibition with tipifamib (RI15777. ZARNESTRA).
L'invention concerne un simple dosage d'expression à deux gènes, RASGRPI:APTX, ayant une utilité dans le diagnostic d'une population de patients atteints de leucémie myéloïde aiguë (AML) plus susceptibles de répondre à une inhibition de la farnésyltransférase avec du tipifamib (RI15777. ZARNESTRA).
Fan Hongtao
Raponi Mitch
Wang Yixin
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Veridex Llc
LandOfFree
Methods of determining acute myeloid leukemia response to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of determining acute myeloid leukemia response to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of determining acute myeloid leukemia response to... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1373624